Hangzhou Zede Medical Technology
Latest round
- Series A
Last raised
- Dec 2018
Total raised
- Undisclosed
Investors
- 1
About Hangzhou Zede Medical Technology
Based in Hangzhou, China and established in 2013, Hangzhou Zede Medical Technology focuses of developing and researching new drug in terms of bio-pharmaceuticals and chemical pharmaceutical.
Who invested in Hangzhou Zede Medical Technology
1 investor across 2 rounds
See all investors in Hangzhou Zede Medical Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hangzhou Zede Medical Technology
Who invested in Hangzhou Zede Medical Technology?
Hangzhou Zede Medical Technology has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Zede Medical Technology raised?
Hangzhou Zede Medical Technology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Hangzhou Zede Medical Technology last raise money?
Hangzhou Zede Medical Technology's most recent round on record is a Series A, in Dec 2018.
What does Hangzhou Zede Medical Technology do?
Based in Hangzhou, China and established in 2013, Hangzhou Zede Medical Technology focuses of developing and researching new drug in terms of bio-pharmaceuticals and chemical pharmaceutical.
Where is Hangzhou Zede Medical Technology headquartered?
Hangzhou Zede Medical Technology is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Zede Medical Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Hangzhou Zede Medical Technology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Hangzhou Zede Medical Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.